Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing small molecules that selectively inhibit Bromodomain and ExtraTerminal domain (BET) proteins, a new and emerging target for high risk vascular diseases.
Price: $0.68 | Change: +$0.03 | %Change: +4.62%
Volume: 23,227 | Day High/Low: 0.68/0.63 | 52 Week High/Low: 0.89/0.435
View modes: 
0 stars

ARGENTINA - KD STILL AHEAD IT APPEARS

“By making this deposit, Argentina confirms once again its unshakeable commitment to meet its obligations to bondholders” said the Argentine ministry Argentina deposited the coupon payment on its...read more
0 stars

DOLLARS FOR DOCS: BASED ON NEW SUNSHINE LAW US

Don't Miss: Treatment Tracker Tobacco Bonds Dollars for Docs Segregation Freedom Summer Fracking ...read more
0 stars

RE:ZENITH IPO

This is how BMO sees technicals for RVX:  G1945V _________________________________________________________________________ Highlights Long-Term: More than 9 months Technical Events 3 bullish...read more
3 stars

ZENITH IPO

Our best hope...IMHO over the short term..a long, long wait on RVX with trials and then some..even if the trials succeed.  rate and reply
5 stars

BET inhibition and atherosclerosis

I am not really sure why the SP tanks these day, however, the scientfic background for believing that BET inhibition fights athersclerosis gets stronger and stronger. Last week, the following came out...read more
0 stars

RE ZENITH TRIALS / INTERESTING POST ON OTHER BOARD BY FUNDEM

fOR THOSE OF INTEREST, FYI: Re completion dates for ZEN003365. For those concerned about the length of these trials, listen at the 2:52-3:07 segment.  Given what we’ve read, seen, and...read more
0 stars

RE:RE:RE:RE:RE:RE:RE:WAITING ON REMACE!

GV, CONSIDERING MY PRIOR RESPONSE, AND ON REFLECTION, I MAY HAVE BEEN UN FAIR TO RUSSO ET AL. I REALLY HAVE NO MATERIAL BASIS TO RASH JUDGE THEM, AND FOR THAT I APOLOGIZE TO THIS BOARD. thanks,jk  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:WAITING ON REMACE!

Touche'GV! thanks, jk  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:WAITING ON REMACE!

jk: Small  retail investors are pretty much trading RVX stock. There were a total 87,950 shares traded on Friday. Number of trades 53. That is an average of 1650 shares per trade.  I believe that...read more
0 stars

RE:RE:RE:RE:RE:WAITING ON REMACE!

Sad, sad, sad, GV, but true! I WILL NEVER UNDERSTAND WHY THE ONLY FOLKS THAT WANT RVX SARES ARE PEOPLE RVX PAYS AND THE POSTERS ON THIS BOARD. WONDER HOW MANY SHARES RUSSO AND PARTNERS,LLC. HOLD? SAD,...read more
0 stars

RE:RE:RE:RE:WAITING ON REMACE!

Well on June 27 & 28, 2013 the SP stood at 23 cents. On July 2 , 2013 it climbed to 58 cents. This part Friday's S/P closed at 63 cents. Close enough to July 2013, S/P.  That same opportunity is...read more
5 stars

RE:RE:RE:WAITING ON REMACE!

For all the longs the past several years have been a roller coaster and tumultuous experience and if I had a crystal ball I would bought as many shares as possible in early July 2013 knowing what we...read more
0 stars

RE:RE:WAITING ON REMACE!

Thanks,PRICELESS I AGREE 100%. THAT IS WHY I HAVE BEEN LONG THROUGH THICK AND THIN. I AM ALREADY ON CRESTOR SO ALL I NEED TO BE ABLE TO MAKE 3 TO 5 MORE YEARS IS PARTICIPATION IN THE TRIAL OF RVX-208....read more
0 stars

RE:WAITING ON REMACE!

What gives me some comfort is the understanding that it can easily take up to 20 years to take a potential drug/molecule from pre clinical to FDA approval let alone a billions.  So far rvx 208 is been...read more
0 stars

RE:RE:RE:RE:RE:Had to add today.....

Many thanks, Ronry. jk  rate and reply
0 stars

WAITING ON REMACE!

FYI; I WONDER IF DM COULD USE nPRUV AND FINALLY GET REMACE STARTED? In two minutes, Summer Rogers said it all. The founder and CEO of San Diego-based nPruv said she founded the Web-based health...read more
3 stars

RE:RE:RE:RE:Had to add today.....

We don't discuss it but he still,thinks the space is a loser and that shareholders will,lose most of their money...I think the same can be said for lots other other biotech stocks. No space for the...read more
0 stars

RE:RE:BIOPHARMA AMERICA DAY 3

CTI CONTINUED/CVD AND METABOLIC DISEASE INTEREST ( RIGHT UP THE DM ALLEY I WOULD FIGURE) : Skip to main content ...read more
0 stars

RE:BIOPHARMA AMERICA DAY 3

CTI MENTIONED IN DAY 3: WONDER IF RVX OR ZENITH RUBBED THEIR SHOULDERS AT THE MEETING? Therapeutic Areas» Science...read more
5 stars

BIOPHARMA AMERICA DAY 3

FYI: BioPharm America™: Eight Facts from Day 3 On our third and final day of BioPharm America™highlighted academic innovators and shared why being a part of an innovation hub – like here...read more